Erika Finanger

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli et al. · The Lancet · 2017 · 446 citations · Full text

Rare Diseases, Urology, Clinical Trials +5

Natural history of infantile‐onset spinal muscular atrophy

Stephen J. Kolb, Christopher S. Coffey, Jon Yankey et al. · Annals of Neurology · 2017 · 392 citations · Full text

Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort

Rebecca J. Willcocks, William D. Rooney, William Triplett et al. · Annals of Neurology · 2016 · 162 citations · Full text

Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS

Ishu Arpan, Rebecca J. Willcocks, Sean C. Forbes et al. · Neurology · 2014 · 160 citations · Full text

Baseline results of the Neuro<scp>NEXT</scp> spinal muscular atrophy infant biomarker study

Stephen J. Kolb, Christopher S. Coffey, Jon Yankey et al. · Annals of Clinical and Translational Neurology · 2016 · 121 citations · Full text